Recruitment And Diversity

  1. Moderna Addresses Awareness Gap, Builds Community Trust To Boost CMV Trial Recruitment 9/20/2023

    Fewer than one in four Americans are aware of the leading cause of pediatric birth defects — a common and contagious viral infection known as cytomegalovirus, (CMV). Moderna aims to overcome this awareness gap and enroll patients in CMV trials using lessons learned from its COVID-19 clinical trials.

  2. Best Practices For Identifying And Partnering With Patient Advocacy Organizations 9/15/2023

    When considering best practices for identifying and partnering with patient advocacy organizations (PAOs), it’s important to recognize that the process is a lengthy one that requires considerable forethought and planning. And why shouldn’t it be? In many respects, the work is similar to that performed by your colleagues in commercial and medical affairs.

  3. What Do You MENA? The Arab World And Its Opportunities For Clinical Research 9/6/2023

    Looking beyond the imperative of involving more Arab Americans in clinical trials, there’s more to be said about involving the Middle East and North Africa (MENA) region in clinical research. Arab Board of Clinical Research Chair and President Hadi Danawi, Ph.D. explores the challenges to and benefits of conducting clinical trials in this underserved region.

  4. Considerations For Engaging Arab Americans In Clinical Research 9/1/2023

    The Arab American community has long been lumped into the category of white, despite having their own distinct differences in culture, language, religion, customs, and social norms. Given their uniqueness, recruiting and enrolling Arab Americans in clinical trials requires a culturally sensitive and tailored approach. Here's how to do it.

  5. Where Are All The Arabs? And How A U.S. Census Change Could Improve Clinical Trial Diversity 8/25/2023

    Did you know that Arabs are categorized as white in clinical research? The problem with that designation is multifaceted. Herein, Arab Board for Clinical Research Chair and President Hadi Danawi, Ph.D. why that designation is problematic for clinical research and how change at the U.S. Census Bureau can help.

  6. Pairing Conversion Rates With Patient Personas To Better Understand Enrollment Challenges 8/18/2023

    Patient recruitment doesn't come easy. To help, consider creating patient personas to help understand patient needs and motivations. Nooma Group Managing Partner Tirrell Payton explains how patient personas and conversion rates can help guide you in understanding your target patient populations and potential barriers to their recruitment.

  7. Diversifying Site Location, Trial Design, & Community Partnerships To Drive Diversity In Clinical Trials 8/2/2023

    Creating a diverse and equitable clinical trial requires strategic planning and careful execution — and a balanced approach. Experts at Mirati Therapeutics show how intentional site selection, trial design, and community relationships result in more diverse patient populations for clinical research.

  8. Study Participant Consenting — Can We Do A Better Job? 7/24/2023

    Informed consent documents (ICDs) can be long and complicated, for consenting patients, for auditors, and, sometimes, for regulators. So what can be done to make them better? Guest expert Kamila Novak shares real-life examples of ICDs gone wrong and a few ways to make things right.

  9. Why Do So Many Alzheimer's Clinical Trials Fail? 7/19/2023

    Over the past 20 years, 98% of Alzheimer’s disease treatment clinical trials have failed. But why? INmune Bio CEO and Chief Medical Officer RJ Tesi, MD explores what he says are the three main reasons why so few AD clinical trials succeed.

  10. Building Health Equity By Minimizing Barriers To Clinical Trial Participation 7/5/2023

    The pharmaceutical industry continuously works to address the unmet needs of patients, including the need for therapies that work for as many people as possible. Yet, we continue to see a lack of diversity in clinical trials. Janssen's Lisa Lewis details how we can all come together to improve patient diversity and improve outcomes for all people.